The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| QDEL | -50.1% | -85.63% | -32.16% | +17% |
| S&P | +20.78% | +72.15% | +11.48% | +3,941% |
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings.
QuidelOrtho Corporation's stock has been falling for multiple years, but after a board member purchased shares, could the stock soon reverse?
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $723.30M | 2.1% |
| Gross Profit | $274.60M | -1.4% |
| Gross Margin | 37.96% | -1.4% |
| Market Cap | $1.94B | -35.2% |
| Market Cap / Employee | $298.48K | 0.0% |
| Employees | 6.5K | -1.5% |
| Net Income | -$130,700.00K | 14.8% |
| EBITDA | $75.00M | -40.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $169.80M | 72.7% |
| Accounts Receivable | $451.70M | 43.4% |
| Inventory | 577.6 | 8.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.63B | 13.8% |
| Short Term Debt | $207.60M | -44.3% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -17.77% | 8.3% |
| Return On Invested Capital | 11.79% | -10.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $86.60M | 424.8% |
| Operating Free Cash Flow | $131.90M | 107.1% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.79 | 0.65 | 0.71 | 0.95 | 1.36% |
| Price to Sales | 0.85 | 0.71 | 0.71 | 0.73 | -31.91% |
| Price to Tangible Book Value | -5.87 | -5.24 | -3.44 | -3.39 | -56.96% |
| Price to Free Cash Flow TTM | 150.35 | - | |||
| Enterprise Value to EBITDA | 31.15 | 41.85 | 29.59 | 62.09 | 39.44% |
| Free Cash Flow Yield | 0.7% | - | |||
| Return on Equity | -10.6% | -14.8% | -44.2% | -46.1% | -9.04% |
| Total Debt | $2.69B | $2.79B | $2.84B | $2.83B | 5.69% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
